Drug Profile
Metabotropic glutamate 2/3 receptor agonist - Eli Lilly and Company
Alternative Names: mGlu2/3 Agonist - Eli Lilly and CompanyLatest Information Update: 28 Oct 2015
Price :
$50
*
At a glance
- Originator Eli Lilly and Company
- Class Small molecules
- Mechanism of Action Metabotropic glutamate receptor 2 agonists; Metabotropic glutamate receptor 3 agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Pain
Most Recent Events
- 23 Jan 2014 Phase-I clinical trials in Pain in USA (unspecified route)